Results of a new clinical drug trial offer much-needed hope for people living with multiple sclerosis (MS) — a neurological condition that affects primarily women and has limited treatment options. The results of the trial, published in the New England Journal of Medicine, suggest that the drug, Idudilast, can effectively slow down brain atrophy, or shrinkage. … Continue reading New Treatment for Multiple Sclerosis Reduces Brain Shrinkage by 50 Percent